Phase II trial of irinotecan + 5-fluorouracil + leucovorin [folinic acid] + oxaliplatin as first-line treatment for metastatic colorectal cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Dec 2016 Biomarkers information updated
- 24 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 04 Mar 2008 Status changed from in progress to completed. according to ClinicalTrials.gov